{"name":"AbelZeta Inc.","slug":"abelzeta-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPRjhLdW5DTENtWmFnLUd0SkJLWG5KMGRHNTdZLVRRTjctelc3T2ZzeHJ2N00tSDFHTVNGNkFfaUNKdXY3aU5DamVOVURyOEE5NWNqWEthTmJtV3pUeVBvajgwaTNkQlM0b2VZU3l4WUhpRE5yT0NmV2xDeWtiSnd3UXdVeGZTdkJzeThwZG5weFBzOGhZU3JESXBxWDV0cjFPVlk5STlGa2dqVDk4ZXc?oc=5","date":"2026-01-20","type":"pipeline","source":"BioWorld News","summary":"Astrazeneca expands China cell therapy footprint with Abelzeta CAR T - BioWorld News","headline":"Astrazeneca expands China cell therapy footprint with Abelzeta CAR T","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxQTnhCeElRUllHUDg1U2l6VDZRSFR0NWNjUHpLc3FvaDJ6R3A1aWRpdzhRQ0ctbTF1WS1iZnprNlhHU1dWenRWNjBCSndheXRlMFdYQ05iQUV5dmRYdmY3d29STmlQSUpVbXIxRWdHa29hbjZBcW56MnR2a2hmZWdXYjROa2U0MEJ0bXJpNXdSQmY5eXdvcG1yVE0tV0lWcFpESDZsU1ZKOWtkQTZEeGpRV1AteFFLbGM?oc=5","date":"2026-01-20","type":"deal","source":"BioPharma APAC","summary":"AstraZeneca Acquires Full Global Rights To CCAR031 From AbelZeta Pharma - BioPharma APAC","headline":"AstraZeneca Acquires Full Global Rights To CCAR031 From AbelZeta Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxOUmhNbkJBdWNNM2ZaVzBFNUJQaDVWWmR1LXRsWEtpWkpxWndmeEgwOURIVkRhZlVya2FDMmtvWTVrVVNKcHpOV0lJLVBQSTR5Vmw3TWNCOXdBZWRveXJiOXRSMERrNGQzYzZvbEh2bDdyWFRicm8tV1ZyWWhkcmFBRzhjMHUzcjJJbTJsbFNNdjNoY1lt?oc=5","date":"2026-01-19","type":"deal","source":"Pharmaceutical Technology","summary":"AstraZeneca to acquire China rights for AbelZeta’s CAR-T therapy - Pharmaceutical Technology","headline":"AstraZeneca to acquire China rights for AbelZeta’s CAR-T therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNR3hXcFhTRUQ2bTdUMGlJNU85aDZsN19SNF9GX3NPWjVJdjFxYXNzOGk0S0lSM2tibUhUdVlUX0ktZUtSY3hSdUZLUC1uNmtUOG52SWw2WF9teHJqNXROdWdBaDN5SWEwR1MwUnk2b2tIYUtBVnhlWkRPYVI3Rl83Njc3WFA5WUlXdWpGX1VIcVlVZjVqVWlsLVYyclhzNlo3S2c4NQ?oc=5","date":"2026-01-19","type":"regulatory","source":"Fierce Biotech","summary":"AstraZeneca pens $630M pact to secure remaining rights to armored CAR-T from AbelZeta - Fierce Biotech","headline":"AstraZeneca pens $630M pact to secure remaining rights to armored CAR-T from AbelZeta","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxQUmFNdHpGemtVcHBNTlRjaDlVOVRYRWJBUjlXTUExV0diMi1xckxsZ2x0b2czdE51dEktU21pbHp4Y1QxeFlHMlRINDhsNnpFbEtTYXBMS1BCemEzTmtoOExrYWw3XzVBZWhrajJ3RkZublhabzlBSnBUN2plbExfZG1yOFFTUFVpQTFIb2M5SkJfbmhJQzhjNnhGMU1kY00ydTdMdFlzazF5SHBZM0pKank4VlBwVnY5OVUyTEpCMktPQWtLR3BTWnJ6THpqQWJxM00xdGlGZDVmaGU5S2JsOVZ1a1E5M0xCM3A0YTB3?oc=5","date":"2026-01-18","type":"regulatory","source":"prnewswire.com","summary":"AbelZeta Announces Remaining China Rights to GPC3 Armored CAR-T Therapy to be Acquired by AstraZeneca - prnewswire.com","headline":"AbelZeta Announces Remaining China Rights to GPC3 Armored CAR-T Therapy to be Acquired by AstraZeneca","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE1sc3Rra2R4bDBweGR6M2pfZlU1b192UUZpenptTHZ6dDhJcFFiSkh5czJodjA4blY3Z3JSOVRDbDhZeTVUMWVESnkwWnlrT2dQQ2Rj?oc=5","date":"2026-01-18","type":"deal","source":"FirstWord Pharma","summary":"AstraZeneca buys China CAR-T rights from AbelZeta in $630M deal - FirstWord Pharma","headline":"AstraZeneca buys China CAR-T rights from AbelZeta in $630M deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxNNDliUVdLUnluV2dwU3VHZVpZd3MyLVlnNjgyaXdiSkpGc2lKNVNlMWlJU0lSNUlzZUdTME1GX0tMU0VHbVNnbVZfa2tTNDRzZHNXV2FHd2FIUEV6UFhyemxUU0V1MXdsRkFWOU1HaG1QTVNOR0NUdHdLakdsQ1RFYjJ1MWg5WHRvdkZkT3BFaXRpWHRTZEVtU1ZJbXRfWTc0R3k0REIzM1VPU0lENnp3VGJiZF91SS1ScDl2ZnlmQ1RRb0FQV202R0tWeExuSzUyVzN5ZkJuY3pPakFo?oc=5","date":"2026-01-06","type":"pipeline","source":"prnewswire.com","summary":"AbelZeta to Attend 44th Annual J.P. Morgan Healthcare Conference and Join Panel Discussion - prnewswire.com","headline":"AbelZeta to Attend 44th Annual J.P. Morgan Healthcare Conference and Join Panel Discussion","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-20","type":"trial","source":"prnewswire.com","summary":"AbelZeta Announces Late-Breaking Poster Presentation at ACR Convergence 2025 of First-in-Human Phase I Trial of anti-CD20/BCMA Bispecific CAR-T Therapy in Patients with Refractory Autoimmune Diseases ","headline":"AbelZeta Announces Late-Breaking Poster Presentation at ACR Convergence 2025 of First-in-Human Phase I Trial of anti-CD2","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowJBVV95cUxOai16QzhfaXg0S2RnS0pmQkdXLVQ2Sm51eFBoZFduMzB3WjNqbWkyTFVpVW9MVXZFQW5hQVYzcGN0ZU5CZnpfSDNmTmd5dVJoMTZxclpfMGdKOW5YX2NLeDVDbGwwZVhITHlzOXREV3MyOFFyNU9sbzkwZXFvejFpWDVrc2wxY1JoMlNrZTZxZjRQZzc1bGpFWklEazNwTlJ6ekUzYV9UX0ZpdzR3cVlTNUdfdXVQOW5EREdyY2dOQ3N1R3ZILXpmV1lGS25pZ0pJZW9OVmR0X1V6MXNBdHJ0RjFTay0yamVXb0NMWmxMN0laanlhUEt1Nm1SeHNBdHRual8yRGUtWHFmc2phVDhhNHFKdGZIVU9BLUdVbGJKS3daWlE?oc=5","date":"2025-06-16","type":"pipeline","source":"prnewswire.com","summary":"AbelZeta Announces Promising Long-Term Outcomes for C-CAR039, a Novel CD19/CD20 Bi-Specific CAR-T Therapy, in Patients with R/R B NHL at EHA 2025 - prnewswire.com","headline":"AbelZeta Announces Promising Long-Term Outcomes for C-CAR039, a Novel CD19/CD20 Bi-Specific CAR-T Therapy, in Patients w","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNODduYmt3c1BVTDZIX3NsY3JUbnJPRVF5dDZQMlRjWm1ISmFQaV9tNXlZdU1QaTZYNTdSU0ZISFJqUGtsLVJ4aXU4ZWZ2Q1pjQWJvak4wbXRIeFJhUTU1d3RuZi1SeDhNMFBoYjNPMTVUM1RBNU9WdkFaMFhVTklpWmstMm8zS2lR?oc=5","date":"2023-12-08","type":"deal","source":"Pharmaceutical Technology","summary":"AbelZeta and AstraZeneca enter CAR-T cell therapy development deal - Pharmaceutical Technology","headline":"AbelZeta and AstraZeneca enter CAR-T cell therapy development deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxQWGFVcEhtNV9vdTRfeklQbEFrR19VeFNMb2tOSnNxVWtlcEc0VzJTUkRMbVoyNlBZbnJuR1BJdFliY3lpZUVZdzU5V3FZZXRkendSRzlvU3JRZ1pGNGlYVFRITFJiamhOb1ZPZE0zR2dkdjBIdFV4Zi1WOWNUV2thdXZJUnJ4ZTdSaFdRTEJxVFNCcVo2Ymx6X1BHeG1WTnh6TWRRQTJSWkdfMFNUazd2bG44V0JhNERxcVNUWGxEVmJTNjZUdzR5Z3JIUGx6cnhSV1U3S3AwTTd0LWhrQ2xB?oc=5","date":"2023-12-07","type":"pipeline","source":"BioSpace","summary":"AbelZeta Pharma Announces Agreement with AstraZeneca to Co-Develop a novel Glypican 3 (GPC3) Armored CAR-T Therapy in China - BioSpace","headline":"AbelZeta Pharma Announces Agreement with AstraZeneca to Co-Develop a novel Glypican 3 (GPC3) Armored CAR-T Therapy in Ch","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQRHNvLVIwYVF6YlRVS1NXOFBfeGtSVG9Ec0o5c3YzOGZwN1lLSVRvb0NMOXZZc3EwY0ZfNUc5Z1pLb19kZmxMUkhJSGdYTEFiZWV0Z3lWMUp1ZU1yMm4tN1kxZHpXd1FaZXZCb3hSbUkwa2J5N2ZfckU1bTBHZU5RSlJJUTg4ajRjakNJ?oc=5","date":"2023-11-20","type":"pipeline","source":"BioSpace","summary":"CBMG Holdings Announces Name Change to AbelZeta Pharma, Inc. - BioSpace","headline":"CBMG Holdings Announces Name Change to AbelZeta Pharma, Inc.","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}